About this trial
The prevalence of dyslipidemia is high among patients with hypertension and diabetes mellitus, which increases the risk of cardiovascular disease. However, many patients lack awareness and adherence to treatment and lifestyle modifications. Therefore, a more structured and intensive approach to management and education is required.
This study aims to implement intensive dyslipidemia management and education for patients registered at the Hanam City Hypertension and Diabetes Education Center and evaluate changes in blood lipid levels accordingly. Additionally, the study will analyze the impact of intensive education on patients' quality of life, health behaviors, and treatment adherence, ultimately contributing to the development of effective management strategies.
Eligibility criteria
Qualifiers
Patients registered in the Hanam City Hypertension and Diabetes Program
Adults aged 30 to 80 years
Individuals who have provided written informed consent to participate in the study
Disqualifiers
Chronic kidney disease stage 4 or higher (eGFR <30 mL/min/1.73m²)
Patients with liver cirrhosis or severe liver disease
Patients with a history of acute coronary syndrome within the past 6 months
Pregnant or breastfeeding women • Individuals with psychiatric disorders that may affect study participation
Trial design
Treatments tested in this trial
- centralized management and education group
Treatment groups
Sponsors and collaborators
Saint Vincent's Hospital, Korea
Lead sponsor
Hanam City Center for Hypertension and Diabetes Registration
Collaborator
Korean Center for Disease Control and Prevention
Collaborator